Chemelion will develop cell-scale technology to address chronic disease.

Chronic disease is incurable because of the limited targeting precision of macroscopic instruments and drug treatments:

• Drugs typically also kill or damage healthy cells while attempting to eradicate pathogens or disease.
• Physicians lack fine-grain surgical and diagnostic tools for when diseased tissues are finely intertwined with healthy tissues
• Especially for life-threatening cancers, vascular diseases and diabetes, neurodegenerative,
  lymphatic and sensory diseases,

           and the majority of critical and high morbidity illnesses

Chemelion’s robocytes will provide cell-scale technology
for diagnostics and surgery